SRC and MEK Co-inhibition Synergistically Enhances the Anti-tumor Effect in Both Non-Small Cell Lung Cancer (NSCLC) and Erlotinib-resistant NSCLC User montaukwhaler, in the non small cell lung cancer subreddit, 22 Jun 2019